José Eduardo Nogueira Forni

José Eduardo Nogueira Forni

Auto-generated profile, based on publicly available information

José Eduardo Nogueira Forni

Faculdade de Medicina de São José do Rio Preto, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Revista Brasileira de Ortopedia
Verified
Journal Article
Open access
PDF file
ATAndré Wan Wen Tsai
André Wan Wen Tsai
MFMárcio Fin
Márcio Fin
ILIbrahim Afrânio Willi Liu
Ibrahim Afrânio Willi Liu
RFRosana Fontana
Rosana Fontana
SJSérgio Mendonça Melo Junior
Sérgio Mendonça Melo Junior
JFJose Eduardo Nogueira Forni
Jose Eduardo Nogueira Forni
Low back pain (LBP) is a very prevalent clinical condition worldwide. Approximately 90% of the cases are of nonspecific LBP, due to the lack of anatomopathological changes as potential causes of pain. A more assertive therapeutic approach requires identifying red or yellow flags and diagnosing the pain pattern (nociceptive, neuropathic, nociplastic, or mixed pain). Acute LBP prognosis is favorable in most cases, and the therapeutic objective is to prevent chronicity. For chronic LBP, the goals include pain reduction and improvements in functionality and quality of life. In acute and chronic cases, the principle of multimodal analgesia guides the treatment, which combines pharmacological, non-pharmacological, and interventional methods. The most common medications for LBP are simple analgesics, such as paracetamol, muscle relaxants, nonsteroidal antiinflammatory drugs (NSAIDs), and opioid analgesics. Opioids and NSAIDs should be prescribed at the lowest dose and for the shortest possible time. Patients with neuropathic components may receive adjuvant drugs. Phytocannabinoids may play a role when the previous pharmacological treatment fails. Physical methods, including heat, laser, and extracorporeal shock wave therapy, improve local circulation, produce muscle relaxation, and treat the myofascial component. Interventions such as acupuncture and radiofrequency promote peripheral and/or central neuromodulation. Aligning the patient's expectations to the outcomes of the proposed treatments is essential; to do so, we must consider the educational measures, behavioral therapies, and physical rehabilitation.

1 January 2021 in Revista Brasileira de Educação Médica
Verified
Journal Article
Open access
JFJosé Eduardo Nogueira Forni
José Eduardo Nogueira Forni
LLLaura de Souza Lima
Laura de Souza Lima
RORegiane Cristine Campos de Oliveira
Regiane Cristine Campos de Oliveira
FFFábio Argollo Ferreira
Fábio Argollo Ferreira

14 August 2025 in The Journal of Knee Surgery
Verified
Journal Article
Closed access
JFJosé Eduardo N. Forni
José Eduardo N. Forni
CRCaio Henrique N. Rabesquine
Caio Henrique N. Rabesquine
WJWahi Jalikj
Wahi Jalikj
Tibial plateau fractures account for approximately 1% of all fractures and normally occur as low- or high-energy injuries. This study aims to assess risk factors for site infection following external fixation and osteosynthesis of patients with tibial plateau fracture. A retrospective study was conducted involving the records of patients with Schatzker types I, II, III, IV, V, and VI tibial plateau fractures submitted to external fixation by the emergency ward staff, followed by internal fixation with definitive osteosynthesis after improvement of the soft tissues by the knee surgery team. The following data were collected: energy of fracture, presence/absence of exposed fracture, time between injury and emergency care, time between external fixation and definitive osteosynthesis, comorbidities, number of access routes, duration of surgery, number of participants in surgery, type of surgeon (resident or professor), distance from Schanz screws to focus of the fracture, type of fracture according to the Schatzker classification, and patient age. Among the 137 patients studied, mean age was 43.4 ± 13.8 years, 72.9% were male, 5.1% had diabetes; 43% had Schatzker VI tibial fracture; 82.4% of the fractures were caused by high-energy trauma; 90.5% had closed fractures; 100% used an external fixator prior to definitive osteosynthesis; and 49.6% had dual surgical access (medial and lateral). The prevalence of infection at the surgical site was 19.7%. In the comparison of patients with and without infection, a significant difference was found in the distance between the Schanz screws and focus of fracture (p = 0.0093), which was smaller in patients with infection at the surgical site. A longer time of external fixator use was also associated with the occurrence of infection at the surgical site (p = 0.0283). In conclusion, the positioning of Schanz screw that is an important factor for infection of surgical site, with risk of infection higher in individuals with screws closer to the focus of fracture. Duration of external fixator use may also increase risk of infection after definitive osteosynthesis.

1 October 2025 in Revista Brasileira de Ortopedia
Verified
Journal Article
Open access
PDF file
ATAndré Wan Wen Tsai
André Wan Wen Tsai
MFMárcio Fin
Márcio Fin
ILIbrahim Afrânio Willi Liu
Ibrahim Afrânio Willi Liu
RFRosana Fontana
Rosana Fontana
SJSérgio Mendonça Melo Junior
Sérgio Mendonça Melo Junior
JFJose Eduardo Nogueira Forni
Jose Eduardo Nogueira Forni
Resumo: A dor lombar (DL) é uma condição clínica muito prevalente no mundo. Cerca de 90% dos casos são classificados como lombalgias inespecíficas, pois não há alterações anatomopatológicas que justifiquem sua dor. Para uma abordagem terapêutica mais assertiva, é preciso identificar as bandeiras vermelhas ou amarelas, bem como diagnosticar o padrão de dor (nociceptiva, neuropática, nociplástica ou mista) desses pacientes. Nas lombalgias agudas, a evolução natural é favorável na maioria das vezes, e o objetivo do tratamento é evitar a sua cronificação. Nos casos das lombalgias crônicas, visamos a diminuição da dor, e a melhora da funcionalidade e da qualidade de vida. Tanto nos casos agudos quanto crônicos, guiamos nossas condutas pelo princípio da analgesia multimodal, que combina medidas farmacológicas, não farmacológicas e intervencionistas contra a dor. Entre os medicamentos mais utilizados estão analgésicos simples, como o paracetamol, relaxantes musculares, anti-inflamatórios não esteroidais (AINEs) e os analgésicos opioides. Os AINEs e os opioides, quando indicados, devem ser prescritos na menor dose e pelo menor tempo possível. As medicações adjuvantes estão indicadas na presença do componente neuropático. Os fitocanabinoides são possibilidade quando as drogas anteriores falham. Medidas físicas, como calor, laser e terapia de ondas de choque extracorpórea, melhoram a circulação local, produzem relaxamento muscular e tratam o componente miofascial. Intervenções como acupuntura e radiofrequência promovem neuromodulação periférica e/ou central. Alinhar a expectativa do paciente aos resultados dos tratamentos propostos é fundamental; para isso, devemos considerar as medidas educacionais, terapias comportamentais e a reabilitação física.

1 March 2022 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
JFJosé Eduardo Nogueira Forni
José Eduardo Nogueira Forni
ARAna Carolina Rodrigues
Ana Carolina Rodrigues
ALAmanda Fidalgo Lima
Amanda Fidalgo Lima
BLBianca de Oliveira Lemos
Bianca de Oliveira Lemos
BRBeatriz Arid Rudnick
Beatriz Arid Rudnick
NPNarayana Silva Paiva
Narayana Silva Paiva
Background: Neuropathic pain (NP) is characterized by chronic pain with a generally strong intensity that leads to limitations regarding activities of daily living. Aims and Objectives: The aim of the study was to investigate the effect of B complex vitamins on NP intensity and life quality in patients undergoing hemodialysis. Materials and Methods: A randomized controlled double-blind clinical trial was conducted among hemodialysis patients with clinical diagnosis of NP randomly allocated to two groups: A (gabapentin) and B (B vitamins). DN4, visual analog scale, and Kidney Disease Quality of Life-Short Form questionnaire were used to identify NP, measure pain intensity, and assess quality of life, respectively. Results: A significant reduction in pain occurred after treatment with gabapentin (P=0.003). In the B group, the reduction of pain went from a mean of 7.27 to 5.09 after treatment (P=0.056). In the A group, a significantly poorer quality of life was reported after treatment in the social relations domain (P=0.010). A significant improvement in quality of life and environment domains (P=0.025 and 0.049, respectively) was reported after use of B vitamins. Conclusion: These findings demonstrate that B complex vitamins for the treatment of NP in hemodialysis patients should be investigated further, as this form of treatment contributed to a reduction in pain intensity and suffering with no side effects and at low cost.

1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
JFJosé Eduardo Nogueira Forni
José Eduardo Nogueira Forni